Skip to search formSkip to main contentSkip to account menu

SGN 40

Known as: SGN-14, SGN40 cpd, Monoclonal Antibody SGN-14 
A humanized monoclonal antibody targeting the CD40 antigen with potential antineoplastic activity. CD-40, an integral membrane protein found on the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
We have earlier demonstrated T-cell-independent antitumor effects of a combination of anti-CD40 monoclonal antibody (mAb) and CpG… 
2009
2009
Abstract 2870 Poster Board II-846 Background: Dacetuzumab (SGN-40) is a humanized monoclonal antibody that targets CD40. In prior… 
Review
2008
Review
2008
Understanding the homeostatic mechanisms governing lymphocyte pools achieves critical importance as lymphocyte-targeted therapies… 
2005
2005
SGN-40, a humanized anti-CD40 monoclonal antibody, is being evaluated in a phase I dose escalation study for patients with… 
2005
2005
The vast majority of B-cell malignancies express CD40, a member of the TNF receptor family. This receptor, along with the cognate… 
2000
2000
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs have the capacity to stimulate T-helper (Th)1-type… 
2000
2000
Newborns respond poorly to certain antigens and produce mainly IgM antibodies. By flow cytometry we analyzed on neonatal and… 
1996
Highly Cited
1993
Highly Cited
1993
We studied the ability of B lymphocytes from patients with X‐linked hyper IgM syndrome (HIGM1) to be activated via the CD40…